RESEARCH LETTER
 
TOPICS
REFERENCES (8)
1.
Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet 2019; 393: 2636-46.
 
2.
Batsis JA, Villareal DT. Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies. Nat Rev Endocrinol 2018; 14: 513-37.
 
3.
Thomas DM, Bredlau C, Bosy-Westphal A, et al. Relationships between body roundness with body fat and visceral adipose tissue emerging from a new geometrical model. Obesity 2013; 21: 2264-71.
 
4.
Zhang X, Ma N, Lin Q, et al. Body roundness index and all-cause mortality among US adults. JAMA Netw Open 2024; 7: e2415051.
 
5.
Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci 2014; 69: 547-58.
 
6.
Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 2007; 56: 1010-3.
 
7.
Cleasby ME, Jamieson PM, Atherton PJ. Insulin resistance and sarcopenia: mechanistic links between common co-morbidities. J Endocrinol 2016; 229: R67-81.
 
8.
Meex RCR, Blaak EE, van Loon LJC. Lipotoxicity plays a key role in the development of both insulin resistance and muscle atrophy in patients with type 2 diabetes. Obes Rev 2019; 20: 1205-17.
 
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top